For the past 10 years we have focused on the biology of HIV in semen. Most recently we have used a novel HIV RNA detection strategy to identify people with acute HIV infection. We found that acute HIV infections are remarkably frequent in patients in our STD clinic in Malawi (>2% of all clients, AIDS, 2004). Such patients excrete so much HIV in semen that secondary sexual transmission becomes extremely likely. This renewal Application includes detailed studies of acute HIV infection in Malawi.
In Aim I we will recruit a longitudinal cohort of more than 200 men and women with acute HIV infection, and some of their sexual partners. We will evaluate the ability of simplified testing strategies to identify people with acute HIV infection.
In Aim II we will examine the dynamics of HIV replication in blood and semen to test the hypothesis that the concentration of HIV in semen decreases faster and to a lower level in semen than in blood. We will examine the degree of HIV viral diversity in seminal plasma at the time of transmission, and monitor viral change(s) over time. We will use the heteroduplex tracking assay (HTA) for this purpose. We will use fluorescence in-situ hybridization (FISH) to determine the number of seminal cells infected, and the number of HIV variants per cell. We will determine the infection status of sexual partners, and compare the HIV variants in concordant partners.
In Aim III we will examine the temporal CTL response in patients with acute infection. This response should predict the magnitude of viral burden over time, and the sight(s) of viral mutation. We will examine the CTL response in both HIV postive and negative sexual partners. We will use ELISPOT assays to examine the CTL response in seminal CDS cells. We will undertake prevention efforts directed at HIV negative partners, who are at considerable risk for HIV acquisition. We believe the studies proposed in this Application will provide unique insight into the biology of acute HIV infection and HIV transmission, and information critical for both biological and behavioral prevention strategies.
|Grinsztejn, Beatriz; Hosseinipour, Mina C; Ribaudo, Heather J et al. (2014) Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis 14:281-90|
|Smith, M Kumi; Rutstein, Sarah E; Powers, Kimberly A et al. (2013) The detection and management of early HIV infection: a clinical and public health emergency. J Acquir Immune Defic Syndr 63 Suppl 2:S187-99|
|Cohen, Myron S; Smith, M Kumi; Muessig, Kathryn E et al. (2013) Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet 382:1515-24|
|Thompson, Corbin G; Cohen, Myron S; Kashuba, Angela D M (2013) Antiretroviral pharmacology in mucosal tissues. J Acquir Immune Defic Syndr 63 Suppl 2:S240-7|
|Greener, Benjamin N; Patterson, Kristine B; Prince, Heather M A et al. (2013) Dolutegravir pharmacokinetics in the genital tract and colorectum of HIV-negative men after single and multiple dosing. J Acquir Immune Defic Syndr 64:39-44|
|Abrahams, Melissa-Rose; Treurnicht, Florette K; Ngandu, Nobubelo K et al. (2013) Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression. AIDS 27:507-18|
|Patterson, Kristine B; Prince, Heather A; Stevens, Trenton et al. (2013) Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure. AIDS 27:1413-9|
|Miller, William C; Powers, Kimberly A; Smith, M Kumi et al. (2013) Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis 13:459-64|
|Powers, Kimberly A; Ghani, Azra C; Miller, William C et al. (2011) The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 378:256-68|
|Patterson, Kristine B; Prince, Heather A; Kraft, Eric et al. (2011) Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med 3:112re4|
Showing the most recent 10 out of 27 publications